Newsroom

Industry News

14 Dec

Catalyst Biosciences Announces Appointment of Edward Williams to its Board of Directors

Former Novo Nordisk Executive Strengthens Catalyst’s Hemophilia Expertise SOUTH SAN FRANCISCO, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced the appointment of Edward Williams to the board of directors, effective Jan....

Read more

14 Dec

Tupperware Brands Announces Sale of Beauticontrol Assets to Youngevity International

ORLANDO, FL, Dec. 14, 2017 (GLOBE NEWSWIRE) — Tupperware Brands Corporation (TUP) and Youngevity International, Inc. (YGYI) today announced they have reached an agreement whereby Tupperware Brands will sell Beauticontrol assets to Youngevity, a leading omni-direct lifestyle company. As part of the deal, Youngevity will integrate Beauticontrol’s sales force...

Read more

13 Dec

Monster Digital Receives Requested Extension from Nasdaq Panel

SIMI VALLEY, CA, Dec. 12, 2017 (GLOBE NEWSWIRE) — Monster Digital, Inc. (MSDI) (the “Company” or “Monster Digital”) announced today that on December 11, 2017, it was notified by The NASDAQ Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) granted the Company’s request for continued listing...

Read more

13 Dec

Nephros Receives $1.8 Million in Cash from Sale of Tax Credits

SOUTH ORANGE, NJ, Dec. 13, 2017 (GLOBE NEWSWIRE) — Nephros, Inc. (NEPH) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal...

Read more

12 Dec

Zomedica Announces Achievement of Therapeutic Development Milestones

ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) — Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (ZOM.V) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced a development update on the Company’s four therapeutic candidates for use in companion animals, namely dogs and cats. “We are pleased that we have achieved...

Read more

12 Dec

Trovagene Announces the Launch of NextCollect™ Urine Collection and DNA Preservation Kit to Research Laboratories and Pharmaceutical Customers

SAN DIEGO, Dec. 12, 2017 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced that its proprietary NextCollect™ urine collection and DNA preservation kit is now available, for research use only, to clinical research laboratories and pharmaceutical customers.  NextCollect™ is being offered to both existing contracted clients and...

Read more

11 Dec

Catalyst Biosciences Announces Interim Phase 1/2 CB 2679d/ISU304 Results at the American Society of Hematology Conference

Subcutaneous (SQ) delivery significantly increases half-life of CB 2679d to 98.7 hours Data supports potential normalization of FIX activity with daily or less-frequent SQ dosing SOUTH SAN FRANCISCO, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to...

Read more

Page 4 of 276« First...23456...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address